Jian Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jian Yu has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Hongye Yang
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, China
4 shared publications - Cui Huang
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China
3 shared publications - Lin Zhang
Department of Pharmacy, Shaoxing People’s Hospital, Shaoxing Hospital, Zhejiang University School of Medicine, Shaoxing, China
3 shared publications - Crissy Dudgeon
Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
2 shared publications - Kan He
Center for Stem Cell and Translational Medicine, School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, Anhui, China; Traditional Chinese Medicine Research Centre, School of Life Sciences and Medical Engineering, Anhui University, Hefei 230601, Anhui, China
2 shared publications - Lin Zhang
Department of Forensic Genetics, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan 610041, China
2 shared publications
Latest Publications
- 7 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 21-43
Advancing dentin biomimetic mineralization: From non-collagenous proteins to multifunctional material design
- 7 May 2026
- Published by Elsevier in Acta Biomaterialia
- Vol. 217, 21-43
Advancing dentin biomimetic mineralization: From non-collagenous proteins to multifunctional material design
- 9 March 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (41)
Recent Advances of Mesoporous Nanoparticles in the Management of Dentin Hypersensitivity
Dentin hypersensitivity (DH) is a highly prevalent condition that poses significant clinical and societal challenges. Conventional desensitizers are often hindered by poor dentinal tubule penetration and monofunctional nature. Owing to tunable size and unique porous architecture, mesoporous nanoparticles (MNs) can enter dentinal tubules to form a robust occlusive barrier while simultaneously releasing therapeutic agents, a multifunctional capacity that makes them promising candidates for DH therapy. Beginning with an overview of the etiology and pathogenesis of DH, this review then introduces the developmental characteristics and therapeutic advantages of MNs. After examining the factors that govern drug loading and release from MNs, it focuses on their applications in DH therapy, with particular emphasis on how different component combinations lead to distinct mechanisms of action and varied treatment outcomes. This review concludes by outlining future challenges and opportunities, such as overcoming the physical delivery barriers within dentinal tubules and achieving precise control over remineralization dynamics. Building on this review, the authors propose a multi‑in‑one desensitization strategy that employs a single, multicomponent nanoplatform which, under various actuation mechanisms, concurrently achieves physical occlusion, biomimetic mineralization, biofilm control, and cell‐mediated mineralization for durable and effective treatment of DH.
- 9 March 2026
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (41)
Recent Advances of Mesoporous Nanoparticles in the Management of Dentin Hypersensitivity
Dentin hypersensitivity (DH) is a highly prevalent condition that poses significant clinical and societal challenges. Conventional desensitizers are often hindered by poor dentinal tubule penetration and monofunctional nature. Owing to tunable size and unique porous architecture, mesoporous nanoparticles (MNs) can enter dentinal tubules to form a robust occlusive barrier while simultaneously releasing therapeutic agents, a multifunctional capacity that makes them promising candidates for DH therapy. Beginning with an overview of the etiology and pathogenesis of DH, this review then introduces the developmental characteristics and therapeutic advantages of MNs. After examining the factors that govern drug loading and release from MNs, it focuses on their applications in DH therapy, with particular emphasis on how different component combinations lead to distinct mechanisms of action and varied treatment outcomes. This review concludes by outlining future challenges and opportunities, such as overcoming the physical delivery barriers within dentinal tubules and achieving precise control over remineralization dynamics. Building on this review, the authors propose a multi‑in‑one desensitization strategy that employs a single, multicomponent nanoplatform which, under various actuation mechanisms, concurrently achieves physical occlusion, biomimetic mineralization, biofilm control, and cell‐mediated mineralization for durable and effective treatment of DH.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-6 from Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
PDF - 480KB, Figure S1. Levels of AKT, p-ERK and ERK change following 17AAG treatment; Figure S2. PUMA but not Bim is required for 17AAG-induced apoptosis in HCT 116 cells; Figure S3. PUMA is required for apoptosis induced by other Hsp90 inhibitors; Figure S4. p21 induction suppresses 17AAG-induced apoptosis; Figure S5. p53-KO HCT 116 cells are resistant to apoptosis induced by other Hsp90 inhibitors; Figure S6. 17AAG induces XBP1 splicing but XBP1 siRNA did not affect PUMA induction by 17AAG.
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-6 from Hsp90 Inhibitors Promote p53-Dependent Apoptosis through PUMA and Bax
PDF - 480KB, Figure S1. Levels of AKT, p-ERK and ERK change following 17AAG treatment; Figure S2. PUMA but not Bim is required for 17AAG-induced apoptosis in HCT 116 cells; Figure S3. PUMA is required for apoptosis induced by other Hsp90 inhibitors; Figure S4. p21 induction suppresses 17AAG-induced apoptosis; Figure S5. p53-KO HCT 116 cells are resistant to apoptosis induced by other Hsp90 inhibitors; Figure S6. 17AAG induces XBP1 splicing but XBP1 siRNA did not affect PUMA induction by 17AAG.
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
Supplementary Figures 1-5 from PUMA Induction by FoxO3a Mediates the Anticancer Activities of the Broad-Range Kinase Inhibitor UCN-01
- Open Access
- 29 November 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 23, 394-408
Epigallocatechin-3-gallate/mineralization precursors co-delivery hollow mesoporous nanosystem for synergistic manipulation of dentin exposure
As a global public health focus, oral health plays a vital role in facilitating overall health. Defected teeth characterized by exposure of dentin generally increase the risk of aggravating oral diseases. The exposed dentinal tubules provide channels for irritants and bacterial invasion, leading to dentin hypersensitivity and even pulp inflammation. Cariogenic bacterial adhesion and biofilm formation on dentin are responsible for tooth demineralization and caries. It remains a clinical challenge to achieve the integration of tubule occlusion, collagen mineralization, and antibiofilm functions for managing exposed dentin. To address this issue, an epigallocatechin-3-gallate (EGCG) and poly(allylamine)-stabilized amorphous calcium phosphate (PAH-ACP) co-delivery hollow mesoporous silica (HMS) nanosystem (E/PA@HMS) was herein developed. The application of E/PA@HMS effectively occluded the dentinal tubules with acid- and abrasion-resistant stability and inhibited the biofilm formation of Streptococcus mutans. Intrafibrillar mineralization of collagen fibrils and remineralization of demineralized dentin were induced by E/PA@HMS. The odontogenic differentiation and mineralization of dental pulp cells with high biocompatibility were also promoted. Animal experiments showed that E/PA@HMS durably sealed the tubules and inhibited biofilm growth up to 14 days. Thus, the development of the E/PA@HMS nanosystem provides promising benefits for protecting exposed dentin through the coordinated manipulation of dentin caries and hypersensitivity.
- 29 November 2022
- Published by KEAI Publishing in Bioactive Materials
- Vol. 23, 394-408
Open AccessEpigallocatechin-3-gallate/mineralization precursors co-delivery hollow mesoporous nanosystem for synergistic manipulation of dentin exposure
As a global public health focus, oral health plays a vital role in facilitating overall health. Defected teeth characterized by exposure of dentin generally increase the risk of aggravating oral diseases. The exposed dentinal tubules provide channels for irritants and bacterial invasion, leading to dentin hypersensitivity and even pulp inflammation. Cariogenic bacterial adhesion and biofilm formation on dentin are responsible for tooth demineralization and caries. It remains a clinical challenge to achieve the integration of tubule occlusion, collagen mineralization, and antibiofilm functions for managing exposed dentin. To address this issue, an epigallocatechin-3-gallate (EGCG) and poly(allylamine)-stabilized amorphous calcium phosphate (PAH-ACP) co-delivery hollow mesoporous silica (HMS) nanosystem (E/PA@HMS) was herein developed. The application of E/PA@HMS effectively occluded the dentinal tubules with acid- and abrasion-resistant stability and inhibited the biofilm formation of Streptococcus mutans. Intrafibrillar mineralization of collagen fibrils and remineralization of demineralized dentin were induced by E/PA@HMS. The odontogenic differentiation and mineralization of dental pulp cells with high biocompatibility were also promoted. Animal experiments showed that E/PA@HMS durably sealed the tubules and inhibited biofilm growth up to 14 days. Thus, the development of the E/PA@HMS nanosystem provides promising benefits for protecting exposed dentin through the coordinated manipulation of dentin caries and hypersensitivity.
- 1 November 2020
- Published by Elsevier in Dental Materials
- Vol. 36 (11) , 1452-1463
New perspective to improve dentin-adhesive interface stability by using dimethyl sulfoxide wet-bonding and epigallocatechin-3-gallate
- 1 November 2020
- Published by Elsevier in Dental Materials
- Vol. 36 (11) , 1452-1463
New perspective to improve dentin-adhesive interface stability by using dimethyl sulfoxide wet-bonding and epigallocatechin-3-gallate